Stock Analiz

AbCellera Biologics Inc. (ABCL) stock forecast and price target

Price $11.49 · data as of November 13, 2026

12-month price target

Average target$18.00
Upside / downside+56.7%
Analysts12
ConsensusStrong buy
Low $12.00Average $18.00High $30.00

Gold marker: average target · white marker: today’s price ($11.49)

Analyst ratings

Strong buy 2Buy 10Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.60−23.2%$31M
Next fiscal year
ends December 31, 2027
$-0.70−16.0%$35M
Next quarter
ends December 31, 2026
$-0.16−442.4%$8M
Quarter after
ends December 31, 2026
$-0.17−460.0%$10M

Consensus of the analysts covering AbCellera Biologics, updated daily. In the last 30 days 1 estimates were raised and 3 lowered.

Frequently asked questions

What is the AbCellera Biologics stock price target?

The average 12-month target from 12 analysts is $18.00, 56.7% above the current price of $11.49 Targets range from $12.00 to $30.00.

Is AbCellera Biologics a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 10 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is AbCellera Biologics expected to earn?

Analysts expect EPS of $-0.60 for the fiscal year ending December 31, 2026 and $-0.70 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.